other material
confidence high
sentiment neutral
materiality 0.50
Benitec stockholders approve Nasdaq-related proposal and equity plan amendment at special meeting
Benitec Biopharma Inc.
- 5,947,860 shares (58.97% of outstanding) present at August 29 special meeting.
- Proposal 1 (Nasdaq) approved: 5,868,978 for, 13,614 against, 168 abstain.
- Proposal 2 (amendment to 2020 Equity Plan) approved: 5,024,173 for, 232,406 against, 626,181 abstain.
- Adjournment proposal not presented due to sufficient votes for other proposals.